Experts warn that the federal vaccine advisory group's decision to revisit childhood immunizations and its controversial vote on thimerosal will undermine confidence in vaccines.
Leaders also committed $4.5 billion in additional financing.
In an effort to combat misinformation, a group of volunteers have compiled a growing list of randomized controlled trials conducted for licensed vaccines.
The FDA approved mResvia for the prevention of RSV in people ages 18 to 59 years who are at increased risk for severe disease.
An open letter signed by dozens of medical and public health organizations urges payers and insurers to continue covering COVID vaccines for pregnant patients.
Kennedy said a 'clean sweep' of all 17 current members of the CDC's vaccine advisory board is necessary to re-establish public confidence in vaccines.
Data from 11 Wellcome-funded research projects show that the relationship between vaccination and its impact on AMR is "rarely straightforward."
The company's "next-generation" COVID-19 vaccine, mNexspike, was approved for adults 65 and older and younger people at risk of severe disease.
The agency told vaccine makers that COVID-19 vaccines used in the US starting in fall 2025 should be based on JN.1 lineage strains, preferably the LP.8.1 strain.
Healthcare workers remain the most trusted sources of information (73%), while trust in the federal government to provide factual information rose to 58%.
